Additional experimental work in diabetes showed that administration of Ang-(1–7) limited the activation of NADPH oxidase through downregulation of molecular components of the NADPH oxidase complex [135], thus controlling ROS production and subsequent inflammation. The gene discussed is FMO5; the disease is diabetes mellitus.